These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 32507642)

  • 1. Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children.
    Emonts M; de Bruijne EL; Guimarães AH; Declerck PJ; Leebeek FW; de Maat MP; Rijken DC; Hazelzet JA; Gils A
    J Thromb Haemost; 2008 Feb; 6(2):268-76. PubMed ID: 18021301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice are susceptible to intracerebral thrombosis and ischemic stroke.
    Kraft P; Schwarz T; Meijers JC; Stoll G; Kleinschnitz C
    PLoS One; 2010 Jul; 5(7):e11658. PubMed ID: 20657835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of heparin interaction sites on thrombin-activatable fibrinolysis inhibitor that modulate plasmin-mediated activation, thermal stability, and antifibrinolytic potential.
    Marar TT; Boffa MB
    Res Pract Thromb Haemost; 2024 May; 8(4):102459. PubMed ID: 38983903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma thrombin-activatable fibrinolysis inhibitor and the 1040C/T polymorphism are risk factors for diabetic kidney disease in Chinese patients with type 2 diabetes.
    Huang Q; Feng D; Pan L; Wang H; Wu Y; Zhong B; Gong J; Lin H; Fei X
    PeerJ; 2023; 11():e16352. PubMed ID: 38025709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The crystal structure of thrombin-activable fibrinolysis inhibitor (TAFI) provides the structural basis for its intrinsic activity and the short half-life of TAFIa.
    Anand K; Pallares I; Valnickova Z; Christensen T; Vendrell J; Wendt KU; Schreuder HA; Enghild JJ; Avilés FX
    J Biol Chem; 2008 Oct; 283(43):29416-23. PubMed ID: 18669641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A challenging issue in COVID-19 infection: The relationship between PA1-1 and TAFI levels in patients with coagulation disorder: A retrospective and observational study.
    Altin N; Tiğlioğlu P; Ulusoy TU; Aydin FN; Kar İ; Karakoc B; Utebey G
    Medicine (Baltimore); 2024 Apr; 103(15):e37802. PubMed ID: 38608056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Genes and miRNAs Associated with TAFI-Related Thrombosis: An in Silico Study.
    Rouka E; Zarogiannis SG; Hatzoglou C; Gourgoulianis KI; Malli F
    Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Proteomics Identified TAFI as a Potential Molecule Facilitating the Migration of Peripheral Monocytes to Damaged White Matter During Chronic Cerebral Hypoperfusion.
    Wang Y; Cheng W; Chen X; Cheng C; Zhang L; Huang W
    Neurochem Res; 2024 Mar; 49(3):597-616. PubMed ID: 37978153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis.
    Miljić P; Heylen E; Willemse J; Djordjević V; Radojković D; Colović M; Elezović I; Hendriks D
    Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():74-8. PubMed ID: 20229688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into thrombin activatable fibrinolysis inhibitor function and regulation.
    Foley JH; Kim PY; Mutch NJ; Gils A
    J Thromb Haemost; 2013 Jun; 11 Suppl 1():306-15. PubMed ID: 23809134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there thrombin-activatable fibrinolysis inhibitor in saliva?
    Chopra S; Friman E; Krüger CW; Antovic JP; Naimi-Akbar A
    Br J Oral Maxillofac Surg; 2020 Nov; 58(9):e33-e37. PubMed ID: 32507642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of zinc ions in activation and inactivation of thrombin-activatable fibrinolysis inhibitor.
    Marx PF; Bouma BN; Meijers JC
    Biochemistry; 2002 Jan; 41(4):1211-6. PubMed ID: 11802720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.
    Antovic JP; Blombäck M
    Thromb Res; 2002 Apr; 106(1):59-62. PubMed ID: 12165290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI-mediated inhibition of fibrinolysis.
    Incampo F; Carrieri C; Galasso R; Scaraggi FA; Di Serio F; Woodhams B; Semeraro N; Colucci M
    J Thromb Haemost; 2013 Feb; 11(2):315-24. PubMed ID: 23256818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated levels of activated and inactivated thrombin-activatable fibrinolysis inhibitor in patients with sepsis.
    Park R; Song J; An SS
    Korean J Hematol; 2010 Dec; 45(4):264-8. PubMed ID: 21253429
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.